Muscle Injury Clinical Trial
Official title:
Efficacy and Safety of a Mix of Nicotinamide (NAM) and Pyridoxine (Vitamin B6) on Muscle Regeneration: a Randomized, Double-blind, Placebo-controlled Study ("Satellite-01 Study").
NCT number | NCT04874662 |
Other study ID # | 20.07.CLI |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 3, 2021 |
Est. completion date | May 24, 2022 |
Verified date | November 2021 |
Source | Nestlé |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Assessment of safety and efficacy of NAM/B6 oral administration on the amplification and commitment of satellite cells after a muscle injury
Status | Completed |
Enrollment | 40 |
Est. completion date | May 24, 2022 |
Est. primary completion date | May 24, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 50 Years |
Eligibility | Inclusion Criteria: 1. Males aged =18 = 50 years; 2. Subjects must be in good general health, as determined by the investigator or delegate, based on a comprehensive medical evaluation at screening including detailed medical history, full physical examination, blood pressure and heart rate measurements, 12-lead electrocardiogram (ECG) and clinical laboratory tests; 3. Body mass index (BMI) between18.5 and 24.9 kg/m2; 4. Normal dietary habits; 5. Willing to adhere to the prohibitions and restrictions specified in the protocol; 6. Must understand the nature of the study and be capable of giving written informed consent and be willing to report for the scheduled study visits and communicate to study personnel about adverse events and concomitant medication use. Exclusion Criteria: 1. Subjects presenting with the following blood pressure (BP) and heart rate (HR) values at the screening visit after 10 minutes in supine position: 1. 95 mmHg = systolic blood pressure (SBP) = 140 mmHg, 2. 50 mmHg = diastolic blood pressure (DBP) = 95 mmHg, 3. 50 bpm < HR < 80 bpm, 4. Or any other out of expected range values considered clinically significant by the investigator; 2. Screening visit 12-lead ECG values which are: 1. 120 < PR segment < 220 ms, 2. QRS complex < 120 ms, 3. QTcf < 430 ms, 4. Sign of any trouble of sinusal automatism, 5. Or any other ECG finding considered clinically significant by the investigator; 3. Have any clinically significant abnormalities in serum chemistry, hematology, or urinalysis at screening as judged by the investigator or delegate; 4. Active smokers; 5. Vegetarians or vegans; 6. Performed structured exercises within 3 months prior to participation in the study; 7. History or current use of anabolic steroids and/or growth hormone; 8. Use of corticosteroids within 3 months prior to participation in the study; 9. Current use of anticoagulant or anti-aggreging agents; 10. History or current use since 2 weeks before inclusion of any of the prohibited medications as detailed in Section 6.6.2; 11. History or presence of cardiovascular, pulmonary, gastro-intestinal, hepatic, renal, metabolic, hematological, neurologic, musculoskeletal, psychiatric, systemic or infectious disease; 12. History or current use of drugs or alcohol (alcohol consumption > 40 grams/day); 13. Known intolerance to foods containing the ingredients under investigation; 14. Knee pain that prevents application of the electrical muscle stimulation protocol; 15. Subjects who, in the judgment of the investigator, are likely to be non-compliant or uncooperative during the study, or unable to cooperate because of a language problem, poor mental development; 16. Subjects under administrative or legal supervision; 17. Have participated in a clinical study in the last 3 months and received compensation beyond a certain approved and predefined limit. |
Country | Name | City | State |
---|---|---|---|
Denmark | Bisepjerg-Frederiksbjerg Hospital | Copenhagen |
Lead Sponsor | Collaborator |
---|---|
Nestlé |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | immunofluorescence measurement | Number of satellite cells as measured by immunofluorescence (Pax7 and myogenin antibodies to detect amplifying and committed satellite cells, respectively) on sections of muscle biopsies from the stimulated leg (leg 2) at day 4 and day 8 (muscle biopsies: MB3 and MB5), comparing the study intervention (NAM/B6) to the control intervention (placebo) | 9 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05988476 -
Investıgatıon of The Effıciency of Pulsed Electromagnetıc Field Therapy and Stretching Exercises
|
N/A | |
Active, not recruiting |
NCT05344183 -
Immediate and Short-term Effects of Low-level Laser
|
N/A | |
Completed |
NCT05367648 -
Effects of Protein Hydrolysate Supplement on Systemic Muscle Function Markers Following Resistance Type Exercise in Male Subjects
|
N/A | |
Not yet recruiting |
NCT05279196 -
Biological Variables Associated With the Response to Intensive Training in Athletes
|
N/A | |
Completed |
NCT05254470 -
Real-World Experience of Patients Treated for Musculoskeletal Injuries With SAM in Routine Care
|
||
Completed |
NCT03676205 -
Platelet-Rich Plasma in Acute Muscle Injuries
|
Phase 2 | |
Completed |
NCT05827484 -
The Effect of Combined Use of Anti-fibrotic Agent With Platelet Rich Plasma on Skeletal Muscle Healing After Acute Injuries
|
Phase 4 | |
Completed |
NCT04177537 -
Real-World Experience of Athletes Treated With SAM
|
||
Completed |
NCT01525667 -
Safety and Efficacy of IM Injections of PLX-PAD for the Regeneration of Injured Gluteal Musculature After Total Hip Arthroplasty
|
Phase 1/Phase 2 | |
Completed |
NCT04535635 -
Effects of ART® on Lower Limb Myofascial Pain and Function
|
N/A | |
Completed |
NCT04742244 -
Lemon Verbena Extract Oxidative Stress and Muscle Damage
|
N/A | |
Active, not recruiting |
NCT04483986 -
Does Rectus Re-approximation Cause Adhesion After Cesarean Section?
|
N/A | |
Recruiting |
NCT06205537 -
Muscle Health and Recovery in Older Adults
|
N/A | |
Recruiting |
NCT05216666 -
The Role of Surgical Approach on Residual Limping After Total Hip Arthroplasty
|
N/A | |
Completed |
NCT02077413 -
Muscle Injury Prevention & Rehabilitation in Military Personnel
|
N/A | |
Withdrawn |
NCT01497678 -
Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) Coordinating Center
|
N/A | |
Terminated |
NCT01751503 -
Extramembranous and Interosseous Technique of Tibialis Posterior Tendon Transfer
|
N/A | |
Completed |
NCT04586712 -
Efficacy of a Controlled Short-term Trial of Cannabidiol (CBD) Ingestion on Reducing Symptomatic Response and Facilitating Recovery After Induced Muscle Injury
|
Phase 2 | |
Completed |
NCT04123782 -
Focused Shockwave Treatment in the Recovery Process of Acute Muscle Injuries in Soccer Players
|
N/A | |
Not yet recruiting |
NCT01097798 -
To Evaluate the Efficacy and Safety Aliviador Compared to Gelol in Patients With Contusions, Sprains, Trauma and Muscle Injury.
|
Phase 3 |